India’s top drugmaker Sun Pharma beats profit view on specialty drugs demand
May 22 (Reuters) – India's top drugmaker by revenue Sun Pharmaceutical Industries beat quarterly profit estimates on Friday helped by demand for the company's high-margin specialty drugs used to treat complex conditions. The Mumbai-based firm's consolidated net profit stood at 27.14 billion rupees ($283 million) for the quarter ended March 31, from 21.50 billion rupees last year. That was above…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
